Suppr超能文献

21-羟化酶缺乏所致先天性肾上腺皮质增生症表现为男性不育的基因分型:病例报告及文献综述

Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review.

作者信息

Sugino Y, Usui T, Okubo K, Nagahama K, Takahashi T, Okuno H, Hatayama H, Ogawa O, Shimatsu A, Nishiyama H

机构信息

Department of Urology, Kyoto University, Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

出版信息

J Assist Reprod Genet. 2006 Sep-Oct;23(9-10):377-80. doi: 10.1007/s10815-006-9062-0. Epub 2006 Oct 11.

Abstract

We describe here two infertile male patients who were referred to our hospital with azoospermia at the ages of 33 and 30 years, respectively. Hormonal examinations led to a diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency in both patients. Genotyping revealed that the patients had a homozygous I172N and a heterozygous compound I172N/IVS2-13A/C>G mutation, respectively. Glucocorticoid replacement therapy succeeded in improving the seminal status of one patient, but not the other. For the latter patient and his wife, a pregnancy was achieved by testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) following genetic counseling. It is important to investigate genotyping and to classify patients on the basis of genotypic information in order to arrive at better treatment strategies for male infertility; especially in counseling of TESE-ICSI.

摘要

我们在此描述两名不育男性患者,他们分别在33岁和30岁时因无精子症被转诊至我院。激素检查结果显示,两名患者均因21-羟化酶缺乏而被诊断为先天性肾上腺皮质增生症(CAH)。基因分型显示,两名患者分别有纯合子I172N和杂合子复合突变I172N/IVS2-13A/C>G。糖皮质激素替代疗法成功改善了其中一名患者的精液状况,但对另一名患者无效。对于后一名患者及其妻子,在接受遗传咨询后,通过睾丸精子提取(TESE)和卵胞浆内单精子注射(ICSI)成功受孕。为了制定更好的男性不育治疗策略,尤其是在TESE-ICSI咨询中,重要的是要进行基因分型并根据基因信息对患者进行分类。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验